J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, J.
Right arrow Articles by Nicholson, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, J.
Right arrow Articles by Nicholson, A. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 41, 688-696, May 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-{gamma}

Jianwei Fengb, Jihong Hana, S. Freida A. Pearceb, Roy L. Silversteinb, Antonio M. Gotto, Jr.b, David. P. Hajjara, and Andrew C. Nicholsona
a Departments of Pathology, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021
b Medicine, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021

Correspondence to: Andrew C. Nicholson

CD36, a class B scavenger receptor, is a macrophage receptor for oxidized low density lipoprotein (OxLDL) and may play a critical role in atherosclerotic foam cell formation. We have previously demonstrated that OxLDL, macrophage-colony stimulating factor (M-CSF), and interleukin-4 (IL-4) enhanced expression of CD36. The effect of OxLDL on CD36 is due, in part, to its ability to activate the transcription factor, PPAR-{gamma} (peroxisome proliferator activated receptor-{gamma}). Other PPAR-{gamma} ligands (15-deoxy{Delta}12,14 prostaglandin J2 (15d-PGJ2) and the thiazolidinedione class of antidiabetic drugs) also increase CD36 expression. We have now evaluated signaling pathways involved in the induction of CD36. Treatment of RAW264.7 cells (a murine macrophage cell line) with protein kinase C (PKC) activators (diacylglycerol and ingenol) up-regulated CD36 mRNA expression. Specific inhibitors of PKC reduced CD36 expression in a time-dependent manner, while protein kinase A (PKA) and cyclic AMP agonists had no effect on CD36 mRNA expression. PKC inhibitors reduced basal expression of CD36 and blocked induction of CD36 mRNA by 15d-PGJ2, OxLDL and IL-4. In addition, PKC inhibitors decreased both PPAR-{gamma} mRNA and protein expression and blocked induction of CD36 protein surface expression by OxLDL and 15d-PGJ2 in human monocytes, as determined by FACS. 15d-PGJ2 had no effect on translocation of PKC-{alpha} from the cytosol to the plasma membrane.

These results demonstrate that two divergent physiological or pathophysiological agonists utilize a common pathway to up-regulate of CD36 gene expression. This pathway involves initial activation of PKC with subsequent PPAR-{gamma} activation. Defining these signaling pathways is critical for understanding and modulating expression of this scavenger receptor pathway.—Feng, J., J. Han, S. F. A. Pearce, R. L. Silverstein, A. M. Gotto, Jr., D. P. Hajjar, and A. C. Nicholson. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-{gamma}. J. Lipid Res. 2000. 41: 688;–696.

Supplementary key words: CD36, macrophage, scavenger receptor, PKC, PPAR-{gamma}


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
V. L. King, L. A. Cassis, and A. Daugherty
Interleukin-4 Does Not Influence Development of Hypercholesterolemia or Angiotensin II-Induced Atherosclerotic Lesions in Mice
Am. J. Pathol., December 1, 2007; 171(6): 2040 - 2047.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Collot-Teixeira, J. Martin, C. McDermott-Roe, R. Poston, and J. L. McGregor
CD36 and macrophages in atherosclerosis
Cardiovasc Res, August 1, 2007; 75(3): 468 - 477.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Cho, H. H. Szeto, E. Kim, H. Kim, A. T. Tolhurst, and J. T. Pinto
A Novel Cell-permeable Antioxidant Peptide, SS31, Attenuates Ischemic Brain Injury by Down-regulating CD36
J. Biol. Chem., February 16, 2007; 282(7): 4634 - 4642.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
E. L. Bradshaw, X.-A. Li, T. Guerin, W. V. Everson, M. E. Wilson, A. J. Bruce-Keller, R. N. Greenberg, L. Guo, S. A. Ross, and E. J. Smart
Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C
Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1271 - C1278.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. P. Conway and M. Kinter
Dual Role of Peroxiredoxin I in Macrophage-derived Foam Cells
J. Biol. Chem., September 22, 2006; 281(38): 27991 - 28001.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Puig-Kroger, A. Dominguez-Soto, L. Martinez-Munoz, D. Serrano-Gomez, M. Lopez-Bravo, E. Sierra-Filardi, E. Fernandez-Ruiz, N. Ruiz-Velasco, C. Ardavin, Y. Groner, et al.
RUNX3 Negatively Regulates CD36 Expression in Myeloid Cell Lines
J. Immunol., August 15, 2006; 177(4): 2107 - 2114.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
N. Takeda, I. Manabe, T. Shindo, H. Iwata, S. Iimuro, H. Kagechika, K. Shudo, and R. Nagai
Synthetic Retinoid Am80 Reduces Scavenger Receptor Expression and Atherosclerosis in Mice by Inhibiting IL-6
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1177 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Munteanu, M. Taddei, I. Tamburini, E. Bergamini, A. Azzi, and J.-M. Zingg
Antagonistic Effects of Oxidized Low Density Lipoprotein and {alpha}-Tocopherol on CD36 Scavenger Receptor Expression in Monocytes: INVOLVEMENT OF PROTEIN KINASE B AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{gamma}
J. Biol. Chem., March 10, 2006; 281(10): 6489 - 6497.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
N. Ide, C. Keller, and N. Weiss
Aged Garlic Extract Inhibits Homocysteine-Induced CD36 Expression and Foam Cell Formation in Human Macrophages
J. Nutr., March 1, 2006; 136(3): 755S - 758S.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
A. Daugherty, N. R. Webb, D. L. Rateri, and V. L. King
Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis
J. Lipid Res., September 1, 2005; 46(9): 1812 - 1822.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C. Rask-Madsen and G. L. King
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 487 - 496.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. S. Major, M. T. Wilson, J. L. McCaleb, Y. Ru Su, A. K. Stanic, S. Joyce, L. Van Kaer, S. Fazio, and M. F. Linton
Quantitative and Qualitative Differences in Proatherogenic NKT Cells in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2351 - 2357.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
R. F. Klein, J. Allard, Z. Avnur, T. Nikolcheva, D. Rotstein, A. S. Carlos, M. Shea, R. V. Waters, J. K. Belknap, G. Peltz, et al.
Regulation of Bone Mass in Mice by the Lipoxygenase Gene Alox15
Science, January 9, 2004; 303(5655): 229 - 232.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Sun, A. C. Nicholson, D. P. Hajjar, A. M. Gotto Jr., and J. Han
Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line
J. Lipid Res., October 1, 2003; 44(10): 1877 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. M. Wilmsen, T. P. Ciaraldi, L. Carter, N. Reehman, S. R. Mudaliar, and R. R. Henry
Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E354 - E362.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
F. Sennlaub, F. Valamanesh, A. Vazquez-Tello, A.M. El-Asrar, D. Checchin, S. Brault, F. Gobeil, M.H. Beauchamp, B. Mwaikambo, Y. Courtois, et al.
Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy
Circulation, July 15, 2003; 108(2): 198 - 204.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C.A. Argmann, C.G. Sawyez, C.J. McNeil, R.A. Hegele, and M.W. Huff
Activation of Peroxisome Proliferator-Activated Receptor Gamma and Retinoid X Receptor Results in Net Depletion of Cellular Cholesteryl Esters in Macrophages Exposed to Oxidized Lipoproteins
Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Zou, C. C. DiRusso, V. Ctrnacta, and P. N. Black
Fatty Acid Transport in Saccharomyces cerevisiae. DIRECTED MUTAGENESIS OF FAT1 DISTINGUISHES THE BIOCHEMICAL ACTIVITIES ASSOCIATED WITH Fat1p
J. Biol. Chem., August 16, 2002; 277(34): 31062 - 31071.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. E. Akiyama, S. Sakai, G. Lambert, C. J. Nicol, K. Matsusue, S. Pimprale, Y.-H. Lee, M. Ricote, C. K. Glass, H. B. Brewer Jr., et al.
Conditional Disruption of the Peroxisome Proliferator-Activated Receptor {gamma} Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux
Mol. Cell. Biol., April 15, 2002; 22(8): 2607 - 2619.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M.-C. Beauchamp and G. Renier
Homocysteine Induces Protein Kinase C Activation and Stimulates c-Fos and Lipoprotein Lipase Expression in Macrophages
Diabetes, April 1, 2002; 51(4): 1180 - 1187.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
N. SIDELL, S. W. HAN, and S. PARTHASARATHY
Regulation and Modulation of Abnormal Immune Responses in Endometriosis
Ann. N.Y. Acad. Sci., March 1, 2002; 955(1): 159 - 173.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. E. Clay, G.-i. Atsumi, K. P. High, and F. H. Chilton
Early de Novo Gene Expression Is Required for 15-Deoxy-Delta 12,14-prostaglandin J2-induced Apoptosis in Breast Cancer Cells
J. Biol. Chem., December 7, 2001; 276(50): 47131 - 47135.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C. A. Argmann, C. H. Van Den Diepstraten, C. G. Sawyez, J. Y. Edwards, R. A. Hegele, B. M. Wolfe, and M. W. Huff
Transforming Growth Factor-{beta}1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants
Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 2011 - 2018.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. Devaraj, I. Hugou, and I. Jialal
{{alpha}}-Tocopherol decreases CD36 expression in human monocyte-derived macrophages
J. Lipid Res., April 1, 2001; 42(4): 521 - 527.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Z. Chen, S. Ishibashi, S. Perrey, J.-i. Osuga, T. Gotoda, T. Kitamine, Y. Tamura, H. Okazaki, N. Yahagi, Y. Iizuka, et al.
Troglitazone Inhibits Atherosclerosis in Apolipoprotein E-Knockout Mice : Pleiotropic Effects on CD36 Expression and HDL
Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 372 - 377.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. B. Giardina, D. J. Tanner, and R. A. Khalil
Oxidized-LDL Enhances Coronary Vasoconstriction by Increasing the Activity of Protein Kinase C Isoforms {{alpha}} and {{epsilon}}
Hypertension, February 1, 2001; 37(2): 561 - 568.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. S. Davies, A. V. Pontsler, G. K. Marathe, K. A. Harrison, R. C. Murphy, J. C. Hinshaw, G. D. Prestwich, A. St. Hilaire, S. M. Prescott, G. A. Zimmerman, et al.
Oxidized Alkyl Phospholipids Are Specific, High Affinity Peroxisome Proliferator-activated Receptor gamma Ligands and Agonists
J. Biol. Chem., May 4, 2001; 276(19): 16015 - 16023.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.